Other Mommy Eyes a $35M Debut as Horror Dominates 2026

Horror is having a run that feels untouchable this year. After Obsession and Backrooms crushed expectations, the studio floor is buzzing with a specific kind of anxiety and excitement. Everyone is watching to see if the momentum holds through the fall. Other Mommy is the next test case. It is a Universal release wearing the familiar logos of Blumhouse and Atomic Monster. The film has already made noise, leaning heavily on the fact that scary movies are currently the most reliable ticket sellers in the market. It is not just another entry. It is a direct challenge to the year's established giants.

The anticipation is thick, with preview screenings filling seats that would usually be empty for a mid-tier thriller. This is not a quiet release. It is a blockbuster event designed to drown out whatever else is opening that weekend. The mix of a bankable star and a production team with a proven track record creates a high-stakes environment. If the genre is healthy, as the numbers suggest, this film is positioned to ride that energy to a historic start. The industry is betting big on the idea that the audience is ready for more.

The Numbers Behind the Buzz

The financial projections are aggressive, reflecting a level of confidence that is rare for a single title. Variety reports that the film has already pulled in $3.6 million in previews across 2,850 domestic screens. That is a strong signal of genuine audience interest. It suggests the movie is well on its way to a significant opening. The studio expects the weekend gross to land between $22 million and $28 million. However, some forecasts are pushing the total as high as $35 million. That upper end is the number everyone is circling.

These figures place the film in the upper echelon of recent releases. It is not just about making money. It is about setting a benchmark for what a horror film can achieve in the current market. The strong preview numbers indicate that the film has successfully generated the kind of word of mouth that drives audiences into theaters. The genre is clearly resonating with viewers, and the financial backing for these projects reflects that reality. The stakes are high, and the numbers back up the hype.

A Star Power Play

At the center of the film is Jessica Chastain, who takes on a dual role that is central to the plot. She plays Ursula, the mother of a young daughter named Bela, but she also embodies a terrifying entity known as Other Mommy. This entity looks exactly like Ursula, creating a psychological and supernatural threat that haunts the family. The concept of a doppelganger is a classic trope in horror. But the execution here, featuring a major A-list actor, elevates the material significantly. It turns a familiar scare into a personal confrontation. The tension comes from not knowing which version of the mother is real.

The supporting cast is also notable, including Jay Duplass as Ursula's husband Russell. Other names in the cast include Dichen Lachman, Arian Moayed, and Karen Allen. The presence of these actors adds a layer of credibility and appeal to the project. The film is based on the 2024 novel Incidents Around the House by Josh Malerman, a book that won several awards for top horror. This literary pedigree suggests that the story has a solid foundation, which is often a key ingredient in a successful adaptation. The source material has already proven its staying power.

Competing for the Top Spot

The competition this weekend is not insubstantial, but the gap in projections is wide. Last week's champion was Verity, the Colleen Hoover adaptation starring Anne Hathaway. That film also featured a theme of a freaky mother, creating an interesting thematic rivalry between the two releases. However, the financial outlook for Other Mommy is significantly stronger, suggesting it will easily overtake its predecessor. The genre appeal and the marketing push seem to be having the desired effect on audience behavior. The audience is clearly choosing the supernatural over the domestic drama right now.

There is also Sony's The Social Reckoning releasing this week, directed by Aaron Sorkin. This film is a follow-up to The Social Network and focuses on the 2021 Facebook leak. It stars Mikey Madison as whistleblower Frances Haugen and Jeremy Strong as Mark Zuckerberg. Despite its high-profile cast and director, its tracking for an opening in the low single digits, between $5 million and $10 million, highlights the current dominance of the horror genre. The market is clearly favoring the supernatural over the corporate drama right now. The contrast in expectations is stark.

The Viral Factor

Marketing has played a crucial role in building the hype for this release. The trailer for the movie, which features a particularly frightening jump scare involving Chastain as Other Mommy, went viral online. This clip played in front of theatrical screenings and captured the attention of social media users. In an era where organic virality can drive box office performance, this moment was a significant boost for the film. It gave potential viewers a taste of the intensity they could expect from the full feature. The reaction was immediate and widespread.

The effectiveness of this marketing strategy is evident in the preview numbers. The combination of a viral moment and a strong production team has created a perfect storm for the release. The film is not just relying on the name recognition of its star. It is leveraging the power of a specific, shareable moment to drive interest. This approach has proven successful for many horror films in recent years, and it seems to be working again here. The buzz is real and it is translating into ticket sales.

A Year to Remember

The success of Other Mommy is part of a larger trend in the industry. 2026 has been a huge year for horror, with multiple titles achieving strong financial results. This sustained performance suggests that audiences are hungry for the genre, regardless of the season or the specific subject matter. The industry is responding by greenlighting more projects in this space, recognizing the commercial viability and the passionate fan base that horror films possess. The pipeline is full of similar projects, all hoping to catch the same wave.

As the weekend approaches, all eyes will be on the final numbers. Will the film hit the optimistic $35 million mark, or will it settle for the lower end of the prediction? Either way, it is set to be a major player in the box office. The genre is clearly in a strong position, and this release is a testament to that strength. The coming days will reveal just how far the momentum of 2026 can carry this film. The wait is almost over.